{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:28:10Z","timestamp":1793608090978,"version":"4.5.0"},"reference-count":46,"publisher":"The Microbiological Society of Korea","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Microbiol."],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s12275-013-3428-7","type":"journal-article","created":{"date-parts":[[2014,1,2]],"date-time":"2014-01-02T06:21:38Z","timestamp":1388643698000},"page":"866-871","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["DBA\/2 mouse as an animal model for anti-influenza drug efficacy evaluation"],"prefix":"10.71150","volume":"51","author":[{"given":"Jin Il","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sehee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangmoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilseob","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Woong","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon-Yong","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Il","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mee Sook","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-Seong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4586","published-online":{"date-parts":[[2013,12,19]]},"reference":[{"key":"3428_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/jac\/dkg007","volume":"51","author":"FY Aoki","year":"2003","unstructured":"Aoki, F.Y., Macleod, M.D., Paggiaro, P., Carewicz, O., El Sawy, A., Wat, C., Griffiths, M., Waalberg, E., Ward, P., and Group, I.S. 2003. Early administration of oral oseltamivir increases the benefits of influenza treatment. J. Antimicrob. Chemother.\n                  51, 123\u2013129.","journal-title":"J. Antimicrob. Chemother."},{"key":"3428_CR2","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1242\/dmm.007823","volume":"4","author":"JA Belser","year":"2011","unstructured":"Belser, J.A., Katz, J.M., and Tumpey, T.M. 2011. The ferret as a model organism to study influenza A virus infection. Dis. Model. Mech.\n                  4, 575\u2013579.","journal-title":"Dis. Model. Mech."},{"key":"3428_CR3","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1128\/JVI.02742-09","volume":"84","author":"JA Belser","year":"2010","unstructured":"Belser, J.A., Wadford, D.A., Pappas, C., Gustin, K.M., Maines, T.R., Pearce, M.B., Zeng, H., Swayne, D.E., Pantin-Jackwood, M., Katz, J.M., and\n                  et al. 2010. Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice. J. Virol.\n                  84, 4194\u20134203.","journal-title":"J. Virol."},{"key":"3428_CR4","doi-asserted-by":"publisher","first-page":"10417","DOI":"10.1128\/JVI.00514-09","volume":"83","author":"AC Boon","year":"2009","unstructured":"Boon, A.C., deBeauchamp, J., Hollmann, A., Luke, J., Kotb, M., Rowe, S., Finkelstein, D., Neale, G., Lu, L., Williams, R.W., and\n                  et al. 2009. Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice. J. Virol.\n                  83, 10417\u201310426.","journal-title":"J. Virol."},{"key":"3428_CR5","doi-asserted-by":"publisher","first-page":"7662","DOI":"10.1128\/JVI.02444-09","volume":"84","author":"AC Boon","year":"2010","unstructured":"Boon, A.C., deBeauchamp, J., Krauss, S., Rubrum, A., Webb, A.D., Webster, R.G., McElhaney, J., and Webby, R.J. 2010. Cross-reactive neutralizing antibodies directed against pandemic H1N1 2009 virus are protective in a highly sensitive DBA\/2 mouse influenza model. J. Virol.\n                  84, 7662\u20137667.","journal-title":"J. Virol."},{"key":"3428_CR6","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.3390\/v20801530","volume":"2","author":"NM Bouvier","year":"2010","unstructured":"Bouvier, N.M. and Lowen, A.C. 2010. Animal models for influenza virus pathogenesis and transmission. Viruses\n                  2, 1530\u20131563.","journal-title":"Viruses"},{"key":"3428_CR7","doi-asserted-by":"publisher","first-page":"e1000072","DOI":"10.1371\/journal.ppat.1000072","volume":"4","author":"LM Chen","year":"2008","unstructured":"Chen, L.M., Davis, C.T., Zhou, H., Cox, N.J., and Donis, R.O. 2008. Genetic compatibility and virulence of reassortants derived from contemporary avian H5N1 and human H3N2 influenza A viruses. PLoS Pathog.\n                  4, e1000072.","journal-title":"PLoS Pathog."},{"key":"3428_CR8","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/1743-422X-9-212","volume":"9","author":"L Dengler","year":"2012","unstructured":"Dengler, L., May, M., Wilk, E., Bahgat, M.M., and Schughart, K. 2012. Immunization with live virus vaccine protects highly susceptible DBA\/2J mice from lethal influenza A H1N1 infection. Virol. J.\n                  9, 212.","journal-title":"Virol. J."},{"key":"3428_CR9","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1128\/AAC.01312-06","volume":"51","author":"EA Govorkova","year":"2007","unstructured":"Govorkova, E.A., Ilyushina, N.A., Boltz, D.A., Douglas, A., Yilmaz, N., and Webster, R.G. 2007. Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus. Antimicrob. Agents Chemother.\n                  51, 1414\u20131424.","journal-title":"Antimicrob. Agents Chemother."},{"key":"3428_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.antiviral.2011.05.008","volume":"91","author":"EA Govorkova","year":"2011","unstructured":"Govorkova, E.A., Marathe, B.M., Prevost, A., Rehg, J.E., and Webster, R.G. 2011. Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferrets. Antiviral. Res.\n                  91, 81\u201388.","journal-title":"Antiviral. Res."},{"key":"3428_CR11","doi-asserted-by":"publisher","first-page":"4442","DOI":"10.1128\/JVI.02717-09","volume":"84","author":"R Hai","year":"2010","unstructured":"Hai, R., Schmolke, M., Varga, Z.T., Manicassamy, B., Wang, T.T., Belser, J.A., Pearce, M.B., Garcia-Sastre, A., Tumpey, T.M., and Palese, P. 2010. PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models. J. Virol.\n                  84, 4442\u20134450.","journal-title":"J. Virol."},{"key":"3428_CR12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.coviro.2011.09.002","volume":"1","author":"MG Ison","year":"2011","unstructured":"Ison, M.G. 2011. Antivirals and resistance: influenza virus. Curr. Opin. Virol.\n                  1, 563\u2013573.","journal-title":"Curr. Opin. Virol."},{"key":"3428_CR13","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/nature08260","volume":"460","author":"Y Itoh","year":"2009","unstructured":"Itoh, Y., Shinya, K., Kiso, M., Watanabe, T., Sakoda, Y., Hatta, M., Muramoto, Y., Tamura, D., Sakai-Tagawa, Y., Noda, T., and\n                  et al. 2009. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature\n                  460, 1021\u20131025.","journal-title":"Nature"},{"key":"3428_CR14","doi-asserted-by":"publisher","first-page":"e1000990","DOI":"10.1371\/journal.ppat.1000990","volume":"6","author":"AK Kashyap","year":"2010","unstructured":"Kashyap, A.K., Steel, J., Rubrum, A., Estelles, A., Briante, R., Ilyushina, N.A., Xu, L., Swale, R.E., Faynboym, A.M., Foreman, P.K., and\n                  et al. 2010. Protection from the 2009 H1N1 pandemic influenza by an antibody from combinatorial survivor-based libraries. PLoS Pathog.\n                  6, e1000990.","journal-title":"PLoS Pathog."},{"key":"3428_CR15","doi-asserted-by":"publisher","first-page":"7539","DOI":"10.1128\/JVI.00373-13","volume":"87","author":"JI Kim","year":"2013","unstructured":"Kim, J.I., Lee, I., Park, S., Hwang, M.W., Bae, J.Y., Lee, S., Heo, J., Park, M.S., Garcia-Sastre, A., and Park, M.S. 2013. Genetic requirement for hemagglutinin glycosylation and its implications for influenza A H1N1 virus evolution. J. Virol.\n                  87, 7539\u20137549.","journal-title":"J. Virol."},{"key":"3428_CR16","doi-asserted-by":"publisher","first-page":"363","DOI":"10.4167\/jbv.2012.42.4.363","volume":"42","author":"JI Kim","year":"2012","unstructured":"Kim, J.I. and Park, M.S. 2012a. An universal approach to getting ahead for influenza B vaccines. J. Bacteriol. Virol.\n                  42, 363\u2013367.","journal-title":"J. Bacteriol. Virol."},{"key":"3428_CR17","doi-asserted-by":"publisher","first-page":"886","DOI":"10.3349\/ymj.2012.53.5.886","volume":"53","author":"JI Kim","year":"2012","unstructured":"Kim, J.I. and Park, M.S. 2012b. N-linked glycosylation in the hemagglutinin of influenza A viruses. Yonsei Med. J.\n                  53, 886\u2013893.","journal-title":"Yonsei Med. J."},{"key":"3428_CR18","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1073\/pnas.0909603107","volume":"107","author":"M Kiso","year":"2010","unstructured":"Kiso, M., Takahashi, K., Sakai-Tagawa, Y., Shinya, K., Sakabe, S., Le, Q.M., Ozawa, M., Furuta, Y., and Kawaoka, Y. 2010. T-705 (favipiravir) activity against lethal H5N1 influenza A viruses. Proc. Natl. Acad. Sci. USA\n                  107, 882\u2013887.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"3428_CR19","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s12275-010-0120-z","volume":"48","author":"D Kwon","year":"2010","unstructured":"Kwon, D., Shin, K., Kim, S., Ha, Y., Choi, J.H., Yang, J.S., Lee, J.Y., Chae, C., Oh, H.B., and Kang, C. 2010. Replication and pathogenesis of the pandemic (H1N1) 2009 influenza virus in mammalian models. J. Microbiol.\n                  48, 657\u2013662.","journal-title":"J. Microbiol."},{"key":"3428_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4167\/jbv.2013.43.1.9","volume":"43","author":"I Lee","year":"2013","unstructured":"Lee, I., Kim, J.I., and Park, M.S. 2013. Cell-culture-based influenza vaccines as alternatives to egg-based vaccines. J. Bacteriol. Virol.\n                  43, 9\u201317.","journal-title":"J. Bacteriol. Virol."},{"key":"3428_CR21","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1128\/AAC.42.3.647","volume":"42","author":"W Li","year":"1998","unstructured":"Li, W., Escarpe, P.A., Eisenberg, E.J., Cundy, K.C., Sweet, C., Jakeman, K.J., Merson, J., Lew, W., Williams, M., Zhang, L., and\n                  et al. 1998. Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071. Antimicrob. Agents Chemother.\n                  42, 647\u2013653.","journal-title":"Antimicrob. Agents Chemother."},{"key":"3428_CR22","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/srep00972","volume":"2","author":"JP Long","year":"2012","unstructured":"Long, J.P., Vela, E.M., Stark, G.V., Jones, K.J., Miller, S.T., and Bigger, J.E. 2012. Early indicators of disease in ferrets infected with a high dose of avian influenza H5N1. Sci. Rep.\n                  2, 972.","journal-title":"Sci. Rep."},{"key":"3428_CR23","doi-asserted-by":"publisher","first-page":"9988","DOI":"10.1073\/pnas.0604157103","volume":"103","author":"AC Lowen","year":"2006","unstructured":"Lowen, A.C., Mubareka, S., Tumpey, T.M., Garcia-Sastre, A., and Palese, P. 2006. The guinea pig as a transmission model for human influenza viruses. Proc. Natl. Acad. Sci. USA\n                  103, 9988\u20139992.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"3428_CR24","doi-asserted-by":"publisher","first-page":"11788","DOI":"10.1128\/JVI.79.18.11788-11800.2005","volume":"79","author":"TR Maines","year":"2005","unstructured":"Maines, T.R., Lu, X.H., Erb, S.M., Edwards, L., Guarner, J., Greer, P.W., Nguyen, D.C., Szretter, K.J., Chen, L.M., Thawatsupha, P., and\n                  et al. 2005. Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J. Virol.\n                  79, 11788\u201311800.","journal-title":"J. Virol."},{"key":"3428_CR25","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.bbi.2009.10.011","volume":"24","author":"JA Majde","year":"2010","unstructured":"Majde, J.A., Kapas, L., Bohnet, S.G., De, A., and Krueger, J.M. 2010. Attenuation of the influenza virus sickness behavior in mice deficient in Toll-like receptor 3. Brain Behav. Immun.\n                  24, 306\u2013315.","journal-title":"Brain Behav. Immun."},{"key":"3428_CR26","doi-asserted-by":"publisher","first-page":"e1000745","DOI":"10.1371\/journal.ppat.1000745","volume":"6","author":"B Manicassamy","year":"2010","unstructured":"Manicassamy, B., Medina, R.A., Hai, R., Tsibane, T., Stertz, S., Nistal-Villan, E., Palese, P., Basler, C.F., and Garcia-Sastre, A. 2010. Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines. PLoS Pathog\n                  6, e1000745.","journal-title":"PLoS Pathog"},{"key":"3428_CR27","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1128\/AAC.42.3.640","volume":"42","author":"DB Mendel","year":"1998","unstructured":"Mendel, D.B., Tai, C.Y., Escarpe, P.A., Li, W., Sidwell, R.W., Huffman, J.H., Sweet, C., Jakeman, K.J., Merson, J., Lacy, S.A., and\n                  et al. 1998. Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection. Antimicrob. Agents Chemother.\n                  42, 640\u2013646.","journal-title":"Antimicrob. Agents Chemother."},{"key":"3428_CR28","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1750-2659.2011.00231.x","volume":"5","author":"G Neumann","year":"2011","unstructured":"Neumann, G. and Kawaoka, Y. 2011. The first influenza pandemic of the new millennium. Influenza Other Rrespi. Viruses\n                  5, 157\u2013166.","journal-title":"Influenza Other Rrespi. Viruses"},{"key":"3428_CR29","doi-asserted-by":"publisher","first-page":"e31006","DOI":"10.1371\/journal.pone.0031006","volume":"7","author":"JT Nguyen","year":"2012","unstructured":"Nguyen, J.T., Smee, D.F., Barnard, D.L., Julander, J.G., Gross, M., de Jong, M.D., and Went, G.T. 2012. Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses. PLoS One\n                  7, e31006.","journal-title":"PLoS One"},{"key":"3428_CR30","volume-title":"Fields virology","author":"P Palese","year":"2007","unstructured":"Palese, P. and Shaw, M.L. 2007. Orthomyxoviridae: The viruses and their replication. In Knipe, D.M. and Howley, P.M. (eds.), Fields virology, 5th ed. Wolters Kluwer Health\/Lippincott Williams & Wilkins, Philadelphia, USA.","edition":"5th ed."},{"key":"3428_CR31","doi-asserted-by":"publisher","first-page":"284","DOI":"10.4167\/jbv.2012.42.4.284","volume":"42","author":"S Park","year":"2012","unstructured":"Park, S., Kim, J.I., and Park, M.S. 2012. Antiviral agents against influenza viruses. J. Bacteriol. Virol.\n                  42, 284\u2013293.","journal-title":"J. Bacteriol. Virol."},{"key":"3428_CR32","first-page":"12825","volume":"85","author":"N Pica","year":"2011","unstructured":"Pica, N., Iyer, A., Ramos, I., Bouvier, N.M., Fernandez-Sesma, A., Garcia-Sastre, A., Lowen, A.C., Palese, P., and Steel, J. 2011. The DBA.2 mouse is susceptible to disease following infection with a broad, but limited, range of influenza A and B viruses. J. Virol.\n                  85, 12825\u201312829.","journal-title":"mouse is susceptible to disease following infection with a broad, but limited, range of influenza A and B viruses. J. Virol."},{"key":"3428_CR33","first-page":"5","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed, L.J. and Muench, H. 1938. A simple method for estimating fifty percent endpoints. Am. J. Hyg.\n                  27, 5.","journal-title":"Am. J. Hyg."},{"key":"3428_CR34","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.virusres.2011.03.022","volume":"158","author":"S Sakabe","year":"2011","unstructured":"Sakabe, S., Ozawa, M., Takano, R., Iwastuki-Horimoto, K., and Kawaoka, Y. 2011. Mutations in PA, NP, and HA of a pandemic (H1N1) 2009 influenza virus contribute to its adaptation to mice. Virus Res.\n                  158, 124\u2013129.","journal-title":"Virus Res."},{"key":"3428_CR35","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1084\/jem.20051938","volume":"203","author":"R Salomon","year":"2006","unstructured":"Salomon, R., Franks, J., Govorkova, E.A., Ilyushina, N.A., Yen, H.L., Hulse-Post, D.J., Humberd, J., Trichet, M., Rehg, J.E., Webby, R.J., and\n                  et al. 2006. The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A\/Vietnam\/1203\/04. J. Exp. Med.\n                  203, 689\u2013697.","journal-title":"J. Exp. Med."},{"key":"3428_CR36","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1159\/000239382","volume":"41","author":"RW Sidwell","year":"1995","unstructured":"Sidwell, R.W., Bailey, K.W., Wong, M.H., and Huffman, J.H. 1995. In vitro and in vivo sensitivity of a non-mouse-adapted influenza A (Beijing) virus infection to amantadine and ribavirin. Chemotherapy\n                  41, 455\u2013461.","journal-title":"Chemotherapy"},{"key":"3428_CR37","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1128\/AAC.01051-06","volume":"51","author":"RW Sidwell","year":"2007","unstructured":"Sidwell, R.W., Barnard, D.L., Day, C.W., Smee, D.F., Bailey, K.W., Wong, M.H., Morrey, J.D., and Furuta, Y. 2007. Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice. Antimicrob. Agents Chemother.\n                  51, 845\u2013851.","journal-title":"Antimicrob. Agents Chemother."},{"key":"3428_CR38","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1128\/JVI.00101-10","volume":"84","author":"A Solorzano","year":"2010","unstructured":"Solorzano, A., Ye, J., and Perez, D.R. 2010. Alternative live-attenuated influenza vaccines based on modifications in the polymerase genes protect against epidemic and pandemic flu. J. Virol.\n                  84, 4587\u20134596.","journal-title":"J. Virol."},{"key":"3428_CR39","first-page":"492","volume":"61","author":"RA Trammell","year":"2011","unstructured":"Trammell, R.A. and Toth, L.A. 2011. Markers for predicting death as an outcome for mice used in infectious disease research. Comp. Med.\n                  61, 492\u2013498.","journal-title":"Comp. Med."},{"key":"3428_CR40","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1586\/14760584.7.6.783","volume":"7","author":"JW van der Laan","year":"2008","unstructured":"van der Laan, J.W., Herberts, C., Lambkin-Williams, R., Boyers, A., Mann, A.J., and Oxford, J. 2008. Animal models in influenza vaccine testing. Expert. Rev. Vaccines\n                  7, 783\u2013793.","journal-title":"Expert. Rev. Vaccines"},{"key":"3428_CR41","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1128\/AAC.00588-08","volume":"53","author":"Y Wattanagoon","year":"2009","unstructured":"Wattanagoon, Y., Stepniewska, K., Lindegardh, N., Pukrittayakamee, S., Silachamroon, U., Piyaphanee, W., Singtoroj, T., Hanpithakpong, W., Davies, G., Tarning, J., and\n                  et al. 2009. Pharmacokinetics of high-dose oseltamivir in healthy volunteers. Antimicrob. Agents Chemother.\n                  53, 945\u2013952.","journal-title":"Antimicrob. Agents Chemother."},{"key":"3428_CR42","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.1750-2659.2011.00235.x","volume":"5","author":"ZX Wong","year":"2011","unstructured":"Wong, Z.X., Jones, J.E., Anderson, G.P., and Gualano, R.C. 2011. Oseltamivir treatment of mice before or after mild influenza infection reduced cellular and cytokine inflammation in the lung. Influenza Other Respi. Viruses\n                  5, 343\u2013350.","journal-title":"Influenza Other Respi. Viruses"},{"key":"3428_CR43","volume-title":"Fields virology","author":"PF Wright","year":"2007","unstructured":"Wright, P.F. and Webster, R.G. 2007. Orthomyxoviruses. In Knipe, D.M. and Howley, P.M. (eds.), Fields virology, 5th ed. Wolters Kluwer Health\/Lippincott Williams & Wilkins, Philadelphia, USA.","edition":"5th ed."},{"key":"3428_CR44","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.virol.2007.12.029","volume":"374","author":"NE Yun","year":"2008","unstructured":"Yun, N.E., Linde, N.S., Zacks, M.A., Barr, I.G., Hurt, A.C., Smith, J.N., Dziuba, N., Holbrook, M.R., Zhang, L., Kilpatrick, J.M., and\n                  et al. 2008. Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A\/Vietnam\/1203\/04 (H5N1). Virology\n                  374, 198\u2013209.","journal-title":"Virology"},{"key":"3428_CR45","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.lfs.2011.12.014","volume":"90","author":"SG Zarogiannis","year":"2012","unstructured":"Zarogiannis, S.G., Noah, J.W., Jurkuvenaite, A., Steele, C., Matalon, S., and Noah, D.L. 2012. Comparison of ribavirin and oseltamivir in reducing mortality and lung injury in mice infected with mouse adapted A\/California\/04\/2009 (H1N1). Life Sci.\n                  90, 440\u2013445.","journal-title":"Life Sci."},{"key":"3428_CR46","doi-asserted-by":"publisher","first-page":"e33383","DOI":"10.1371\/journal.pone.0033383","volume":"7","author":"W Zhu","year":"2012","unstructured":"Zhu, W., Zhu, Y., Qin, K., Yu, Z., Gao, R., Yu, H., Zhou, J., and Shu, Y. 2012. Mutations in polymerase genes enhanced the virulence of 2009 pandemic H1N1 influenza virus in mice. PLoS One\n                  7, e33383.","journal-title":"PLoS One"}],"container-title":["Journal of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12275-013-3428-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12275-013-3428-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12275-013-3428-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12275-013-3428-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T17:51:28Z","timestamp":1735062688000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12275-013-3428-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["3428"],"URL":"https:\/\/doi.org\/10.1007\/s12275-013-3428-7","relation":{},"ISSN":["1225-8873","1976-3794"],"issn-type":[{"value":"1225-8873","type":"print"},{"value":"1976-3794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"9 August 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}